Cancer Bio-markers

\  

\

\ <p style="\\&quot;text-align:" justify;\\"="">A biomarker may be used to see how well the body responds to a treatment for a disease or condition. A use of biomarkers in cancer research is developing drug targets and Surrogate endpoints.While numerous challenges exist in translating biomarker research into the clinical space; a number of gene and protein based biomarkers have already been used at some point in patient care; including, Liver Cancer, Chronic Myeloid Leukemia BRCA1 / BRCA2 (Breast/Ovarian Cancer), Melanoma/Colorectal Cancer, Ovarian Cancer Pancreatic Cancer

\

\ \\

\

\ \\ Types of cancer biomarkers

\

\ \\

\
    \ \\\
  • \ \\ Breast
  • \ \\\
  • \ \\ Colorectal
  • \ \\\
  • \ \\ Leukemia/Lymphoma
  • \ \\\
  • \ \\ Gastric
  • \ \\\
  • \ \\ Lung
  • \ \\\
  • \ \\ Melanoma
  • \ \\\
  • \ \\ Pancreas
  • \ \\\
\

\ \\

\

\ \\ In cancer research, biomarkers are used in three primary ways

\

\ \\

\
    \ \\\
  • \ \\ To help diagnose conditions, as in the case of identifying early stage cancers (Diagnostic)
  • \ \\\
  • \ \\ To forecast how aggressive a condition is, as in the case of determining a patient's ability to fare in the absence of treatment.
  • \ \\\
  • \ \\ To predict how well a patient will respond to treatment.
  • \ \\\
\

\ \\

\

    Related Conference of Cancer Bio-markers

    March 16-17, 2020

    4th World Congress on Radiology and Oncology

    Dubai, UAE

    Cancer Bio-markers Conference Speakers